التفاصيل البيبلوغرافية
| العنوان: |
Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics. |
| المؤلفون: |
Xiaohua Li, Kelley M. Rosborough, Ari B. Friedman, Wawa Zhu, Kevin A. Roth |
| المصدر: |
International Journal of Neuropsychopharmacology; Feb2007, Vol. 10 Issue 1, p7-19, 13p |
| مصطلحات موضوعية: |
GLYCOGEN synthase kinase-3, PROTEIN kinases, SEROTONIN uptake inhibitors, PHOSPHORYLATION, CHEMICAL reactions, FLUOXETINE, PHARMACOKINETICS |
| مستخلص: |
Glycogen synthase kinase-3 (GSK3) has been recognized as an important enzyme that modulates many aspects of neuronal function. Accumulating evidence implicates abnormal activity of GSK3 in mood disorders and schizophrenia, and GSK3 is a potential protein kinase target for psychotropics used in these disorders. We previously reported that serotonin, a major neurotransmitter involved in mood disorders, regulates GSK3 by acutely increasing its N-terminal serine phosphorylation. The present study was undertaken to further determine if atypical antipsychotics, which have therapeutic effects in both mood disorders and schizophrenia, can regulate phospho-Ser-GSK3 and inhibit its activity. The results showed that acute treatment of mice with risperidone rapidly increased the level of brain phospho-Ser-GSK3 in the cortex, hippocampus, striatum, and cerebellum in a dose-dependent manner. Regulation of phospho-Ser-GSK3 was a shared effect among several atypical antipsychotics, including olanzapine, clozapine, quetiapine, and ziprasidone. In addition, combination treatment of mice with risperidone and a monoamine reuptake inhibitor antidepressant imipramine or fluoxetine elicited larger increases in brain phospho-Ser-GSK3 than each agent alone. Taken together, these results provide new information suggesting that atypical antipsychotics, in addition to mood stabilizers and antidepressants, can inhibit the activity of GSK3. These findings may support the pharmacological mechanisms of atypical antipsychotics in the treatment of mood disorders. [ABSTRACT FROM AUTHOR] |
|
Copyright of International Journal of Neuropsychopharmacology is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
